je.st
news
Home
› bluebird bio Announces Global Strategic Collaboration with Celgene to Advance Gene Therapy in Oncology
bluebird bio Announces Global Strategic Collaboration with Celgene to Advance Gene Therapy in Oncology
2013-03-21 19:37:45| Biotech - Topix.net
The collaboration will focus on applying gene therapy technology to genetically modify a patient's own T-cells, known as chimeric antigen receptor T-cells, to target and destroy cancer cells.
Tags: global
advance
bio
collaboration
Category:Biotechnology and Pharmaceuticals